Investing in innovation with the Parvest Disruptive Technology Fund
Looking to invest in the technological revolutions of the future? In November 2017, BNP Paribas...
03/04/2018
DNA Script, a technology for synthetic DNA production
- 10.11.2017
DNA Script's technology overcomes the current inefficiencies of synthetic DNA production, and enable affordable, rapid, high-quality and high throughput production of synthetic biology tools, such as oligonucleotides, genes, pathways and genomes.
The speech on video
During the issuance “Crash Test” of Figaro, WAI by BNP Paribas and Taddeo, Sylvain Gariel, Co-founder and COO of DNA Script is going to speech: